{
  "trial_id": "NCT01853748",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "HER2-positive Stage I histologically confirmed invasive carcinoma of the breast",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "ER/PR determination is required",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Bilateral breast cancers that individually meet eligibility criteria are allowed",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Subjects with multifocal or multicentric disease are eligible as long as each tumor individually meets eligibility criteria",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Patients with a history of ipsilateral DCIS are eligible if they were treated with wide-excision alone, without radiation therapy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Should have tumor tissue available and a tissue block of sufficient size to make 15 slides, which must be sent to a DFCI site for testing",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Less than or equal to 90 days since most recent breast surgery for this breast cancer",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "All tumor should be removed by either a modified radical mastectomy or a segmental mastectomy (lumpectomy) with either a sentinel node biopsy or axillary dissection",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Must have discontinued any investigational drug at least 2 weeks prior to participation",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Will be willing to use one highly effective form of nonhormonal contraception or two effective forms of nonhormonal contraception while on study and for 7 months after end of study treatment",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Subjects undergoing lumpectomy must have no contraindications to radiation therapy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Prior oophorectomy for cancer prevention is allowed",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Pregnant or breastfeeding",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Use of potent CYP3A4 inhibitors during the study treatment period",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Excessive alcohol intake (more than 3 alcoholic beverages per day)",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Locally advanced tumors at diagnosis",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "History of previous invasive breast cancer",
      "label": "triggers",
      "evidence": "unknown"
    },
    {
      "criterion": "History of prior chemotherapy in the past 5 years",
      "label": "triggers",
      "evidence": "unknown"
    },
    {
      "criterion": "History of prior trastuzumab or prior paclitaxel therapy",
      "label": "triggers",
      "evidence": "unknown"
    },
    {
      "criterion": "Active, unresolved infection",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "notes": "45-year-old postmenopausal woman with cytologically confirmed breast cancer. HER2-positive and ER/PR negative.",
  "_meta": {
    "topic_id": "61",
    "trial_id": "NCT01853748",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}